PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk

Dow Jones11-26 07:11

2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because PolyNovo didn't give a trading update at its annual meeting of shareholders. "Consensus has revenue growth of 29% for FY 2025 which will be skewed to the 2H and we are confident it can be achieved," Morgans says. "Growth of 20%+ is expected to continue in FY26/27 driven by regional expansion as well as additional indications." Morgans has a A$2.85/share price target and add call on PolyNovo, which ended Monday at A$2.04. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

November 25, 2024 18:11 ET (23:11 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486062333?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-26 07:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486062333","market":"nz","top_or_hot":-1,"title":"PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because PolyNovo didn't give a trading update at its annual meeting of shareholders. \"Consensus has revenue growth of 29% for FY 2025 which will be skewed to the 2H and we are confident it can be achieved,\" Morgans says. \"Growth of 20%+ is expected to continue in FY26/27 driven by regional expansion as well as additional indications.\" Morgans has a A$2.85/share price target and add call on PolyNovo, which ended Monday at A$2.04. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 25, 2024 18:11 ET (23:11 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 07:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2486062333","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486062333","pubTimestamp":1732576260,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because PolyNovo didn't give a trading update at its annual meeting of shareholders. \"Consensus has revenue growth of 29% for FY 2025 which will be skewed to the 2H and we are confident it can be achieved,\" Morgans says. \"Growth of 20%+ is expected to continue in FY26/27 driven by regional expansion as well as additional indications.\" Morgans has a A$2.85/share price target and add call on PolyNovo, which ended Monday at A$2.04. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","PNV.AU":"POLYNOVO LTD","BK7126":"医疗保健用品"},"translate_title":"PolyNovo股价回落创造买入机会——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PNV.AU":0.9},"content_text":"2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because PolyNovo didn't give a trading update at its annual meeting of shareholders. \"Consensus has revenue growth of 29% for FY 2025 which will be skewed to the 2H and we are confident it can be achieved,\" Morgans says. \"Growth of 20%+ is expected to continue in FY26/27 driven by regional expansion as well as additional indications.\" Morgans has a A$2.85/share price target and add call on PolyNovo, which ended Monday at A$2.04. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2024 18:11 ET (23:11 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486062333"}